Plasminogen activator inhibitor-1 gene promoter 4G/5G polymorphism and risks of peripherally inserted central catheter –related venous thrombosis in patients with lung cancer: a prospective cohort study
ConclusionOur finding suggested that there is no statistically significant influence of the PAI-1 4G/5G gene variant on PICC-RVT in Chinese patients with lung cancer. However, patients with higher Caprini scores and higher fibrinogen levels are at increased risk for PICC-RVT, as are patients receiving chemotherapy. Clinical staff should carefully perform a risk assessment for patients with PICC. Those with the above risk factors should pay close attention and take timely and effective preventive measures.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research
More News: Alimta | Cancer | Cancer & Oncology | Chemotherapy | China Health | Genetics | Lung Cancer | Statistics | Study | Thrombosis